FDA Advise-ERR: prevent dangerous drug-device interaction causing falsely elevated glucose levels.
This article addresses a drug–device interaction in which patients receiving a certain peritoneal dialysis solution may have falsely elevated blood glucose levels when measured with point-of-care blood glucose monitors.
ISMP Medication Safety Alert! Acute Care Edition. June 19, 2008;13:1-3.